Globus Medical
Ownership
Ownership Structure
Who owns Globus Medical (GMED)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.2% of the shares are freely tradable; institutional investors hold 101.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.05 | 10,806,724 | +2.9 | 06/30/2026 |
| Jupiter Topco LLC | 6.11 | 8,200,423 | +0.0 | 06/30/2026 |
| HHG PLC | 5.68 | 7,623,095 | +4.5 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.80 | 5,107,532 | +1.5 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 3.72 | 4,994,385 | +2.4 | 06/30/2026 |
| Amvescap Plc. | 3.21 | 4,309,771 | -0.2 | 06/30/2026 |
| Kayne Anderson Rudnick Investment Management LLC | 3.19 | 4,279,730 | +0.0 | 06/30/2026 |
| State Street Corp | 2.77 | 3,714,029 | +3.4 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 2.97 | 3,983,485 | +0.0 | 09/30/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.68 | 3,603,635 | +0.3 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Davidar David D | Director | 507,675 | 40,410,930 $ | Jul 27, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Tobin James R | Director | Sell | 30,000 | 74.58 | 2,237,502 |
| Sep 15, 2026 | Tobin James R | Director | Other | 15,000 | 63.68 | 955,200 |
| Aug 18, 2026 | Zarrilli Stephen T | Director | Sell | 25,000 | 87.04 | 2,175,965 |
| Aug 18, 2026 | Zarrilli Stephen T | Director | Other | 25,000 | 53.27 | 1,331,750 |
| Jul 27, 2026 | Davidar David D | Director | Other | 2,500 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.